^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SLAMF7 FPBMC

    i
    Other names: SLAMF7 FPBMC, SLAMF7 BATs/CS-1 BATs, anti-CD3 x anti-SLAMF7 bispecific antibody armed activated T cells
    Associations
    News

    Trials

    Company:
    University of Virginia
    Drug class:
    CS-1 inhibitor, CD3 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma (MM FPBMC) (NCT04864522)
    Phase 1/2
    University of Virginia
    Withdrawn
    Last update posted :
    11/21/2023
    Initiation :
    08/01/2023
    Primary completion :
    11/01/2023
    Completion :
    11/01/2023
    SLAMF7
    |
    SLAMF7 FPBMC